Can repeated MRI scans catch prostate cancer earlier?
NCT ID NCT07369570
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 100 men who have suspicious spots on prostate MRI but no significant cancer on their first biopsy. Over one year, they will have repeat MRI scans and biopsies to see if changes in those spots predict the development of clinically significant prostate cancer. The goal is to improve how doctors monitor and decide when to re-biopsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict which men need follow-up biopsies, reducing unnecessary procedures and catching aggressive cancers earlier.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to immediate changes in care, and results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kuopio University Hospital
RECRUITINGKuopio, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- AI reads scans to spot prostate cancer, spare unnecessary biopsies
- Extra numbing shot may ease pain of prostate biopsy
- Community-Led push to catch prostate cancer early in black men